Published in Arch Neurol on January 01, 2001
Imaging of multiple sclerosis: role in neurotherapeutics. NeuroRx (2005) 0.98
Ring and nodular multiple sclerosis lesions: a retrospective natural history study. Neurology (2010) 0.91
Sensitivity and reproducibility of a new fast 3D segmentation technique for clinical MR-based brain volumetry in multiple sclerosis. Neuroradiology (2004) 0.89
Neuroradiological evaluation of demyelinating disease. Ther Adv Neurol Disord (2013) 0.80
Multiple sclerosis and magnetic resonance imaging: advancement in linking the pictures with the progression. Arch Neurol (2001) 0.77
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36
Distributed and overlapping representations of faces and objects in ventral temporal cortex. Science (2001) 17.40
Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol (2001) 4.54
Immunological aspects of demyelinating diseases. Annu Rev Immunol (1992) 4.39
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat Med (2000) 3.98
Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med (1997) 3.65
Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci U S A (1998) 3.35
Simple correction method for k-space trajectory deviations in MRI. J Magn Reson (1998) 3.35
Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex (1999) 3.31
Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28
The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2003) 3.21
Noise reduction in 3D perfusion imaging by attenuating the static signal in arterial spin tagging (ASSIST). Magn Reson Med (2000) 2.58
Age-dependent resistance to viral encephalitis: studies of infections due to Sindbis virus in mice. J Infect Dis (1972) 2.56
Investigation of low frequency drift in fMRI signal. Neuroimage (1999) 2.49
Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci U S A (1999) 2.42
Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens. J Immunol (1984) 2.21
H(2)(15)O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans. Magn Reson Med (2000) 2.20
Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat Med (1999) 2.11
HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J Virol (1989) 2.11
Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol (1990) 2.07
Perfusion imaging with compensation for asymmetric magnetization transfer effects. Magn Reson Med (1996) 2.03
Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol (1991) 2.00
The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain (1998) 1.96
Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature (1993) 1.89
A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med (1991) 1.84
Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging. Methods Enzymol (2004) 1.82
Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci (1995) 1.82
Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines. AJNR Am J Neuroradiol (2006) 1.78
CD4+CD28- costimulation-independent T cells in multiple sclerosis. J Clin Invest (2001) 1.74
Multiple sclerosis (first of two parts). N Engl J Med (1982) 1.72
Synthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates. J Magn Reson Imaging (1999) 1.70
Thalamic involvement and its impact on clinical disability in patients with multiple sclerosis: a diffusion tensor imaging study at 3T. AJNR Am J Neuroradiol (2009) 1.66
Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology (1990) 1.65
Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Ann Neurol (1996) 1.64
Effects of dextroamphetamine on cognitive performance and cortical activation. Neuroimage (2000) 1.63
Correction for vascular artifacts in cerebral blood flow values measured by using arterial spin tagging techniques. Magn Reson Med (1997) 1.61
The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia. Biol Psychiatry (1999) 1.60
Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol (1993) 1.58
Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology (1998) 1.54
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Neurology (2008) 1.53
Rubella vaccination in the United States: a ten-year review. Epidemiol Rev (1980) 1.53
Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol (1992) 1.50
Diagnostic evaluation of cancer patients with pelvic pain: comparison of scintigraphy, CT, and MR imaging. AJR Am J Roentgenol (1990) 1.48
Hepatic hemosiderosis in non-human primates: quantification of liver iron using different field strengths. Magn Reson Med (1997) 1.46
In vitro studies of cell-mediated immunity in an acute viral infection. J Immunol (1974) 1.46
Magnetic resonance imaging of the rhesus monkey brain: use for stereotactic neurosurgery. Exp Brain Res (1990) 1.45
Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis. Ann Neurol (1998) 1.45
Multislice imaging of quantitative cerebral perfusion with pulsed arterial spin labeling. Magn Reson Med (1998) 1.44
Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides. Proc Natl Acad Sci U S A (1994) 1.41
The effect of measles virus infection on T and B lymphocytes in the mouse. I. Suppression of helper cell activity. J Immunol (1974) 1.40
Serial MR imaging of experimental autoimmune encephalomyelitis induced by human white matter or by chimeric myelin-basic and proteolipid protein in the common marmoset. AJNR Am J Neuroradiol (1999) 1.40
Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J Immunol (1992) 1.40
Specificity of the inflammatory response in viral encephalitis. I. Adoptive immunization of immunosuppressed mice infected with Sindbis virus. J Exp Med (1972) 1.39
Basal ganglia iron in tardive dyskinesia: an MRI study. Biol Psychiatry (1994) 1.39
Hemispheric control of motor function: a whole brain echo planar fMRI study. Psychiatry Res (1998) 1.38
Major impediments to measles elimination. The modern epidemiology of an ancient disease. Am J Dis Child (1985) 1.32
The germline repertoire of T cell receptor beta-chain genes in patients with chronic progressive multiple sclerosis. J Neuroimmunol (1989) 1.32
The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology (1999) 1.31
Induction of subacute murine measles encephalitis by monoclonal antibody to virus haemagglutinin. Nature (1981) 1.30
MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability. Neurology (2006) 1.29
Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology (1992) 1.28
Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Am J Psychiatry (2000) 1.28
The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis. Ann Neurol (1995) 1.27
The role of the peck-food contingency on fixed-interval schedules. J Exp Anal Behav (1975) 1.24
Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. Mult Scler (1995) 1.24
Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry (1996) 1.23
Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis. Brain (2003) 1.22
Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol (1993) 1.20
Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes. Ann Neurol (2001) 1.20
Correspondence of closest gradient voxels--a robust registration algorithm. J Magn Reson Imaging (1997) 1.20
Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. J Infect Dis (2000) 1.19
Abscesses complicating DTP vaccination. Am J Dis Child (1981) 1.19
Chondromyxoid fibroma of the jaws. Case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1998) 1.19
Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS Lyme disease. J Autoimmun (2001) 1.18
Multiple sclerosis (second of two parts). N Engl J Med (1982) 1.18
Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: relationship between relaxivities, electrostatic forces, and chemical composition. Magn Reson Med (2003) 1.17
Measles virus persistence in human lymphocytes: a role for virus-induced interferon. J Gen Virol (1982) 1.17
Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays. Ann Neurol (1999) 1.17
Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology. J Immunol (1998) 1.16
Diphtheria-tetanus toxoids-pertussis vaccination and sudden infant deaths in Tennessee. J Pediatr (1982) 1.16
In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosis. AJNR Am J Neuroradiol (2006) 1.16
Immunopathogenesis of the multiple sclerosis lesion. Curr Neurol Neurosci Rep (2001) 1.16
Relaxometry and magnetometry of the MR contrast agent MION-46L. Magn Reson Med (1999) 1.15
T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity (1993) 1.15
MRI as a marker for disease heterogeneity in multiple sclerosis. Neurology (2005) 1.14
The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia. Neuropsychopharmacology (2000) 1.14
Magnetoferritin: characterization of a novel superparamagnetic MR contrast agent. J Magn Reson Imaging (1994) 1.13
Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease. N Engl J Med (1997) 1.13
Proton MR spectroscopic imaging without water suppression. Radiology (2000) 1.13
Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age. Neurology (1995) 1.12
Localized echo-volume imaging methods for functional MRI. J Magn Reson Imaging (1997) 1.11